Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

NCT06265012 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Marburg Virus Disease

Interventions

BIOLOGICAL: PHV01
BIOLOGICAL: Placebo

Sponsor

Public Health Vaccines LLC

Collaborators

[object Object]